McNeil gelcaps patent
This article was originally published in The Tan Sheet
Executive Summary
Firm's OTCs that use gelatin capsule technology covered by '524 patent include Tylenol cough/cold products, not cough/cold offerings under the Motrin brand, as incorrectly stated in 1"The Tan Sheet" Aug. 5, 2002, p. 13...
You may also be interested in...
McNeil Gelatin Capsules Patent Infringed By Bayer, Jury Says
Two gelcap formulations of Bayer aspirin infringe a McNeil-PPC patent covering dual-colored, gelatin-coated caplets, a jury concluded July 26
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.